• Other mechanisms than the underlying HNPCC-causing mutation are likely to influence tumor development and tumor morphology.
Take home messages
• Tumors that develop as part of the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome display extensive heterogeneity, also when caused by identical germline mutations.
• Other mechanisms than the underlying HNPCC-causing mutation are likely to influence tumor development and tumor morphology.
• HNPCC-associated features, e.g. poor tumor differentiation, an expanding growth pattern, and TIL were more common in proximal compared to distal colon cancers.
• Identification of HNPCC cases among distal colon cancers may be challenging since these tumors often lack the specific histopathologic HNPCC-associated features.
INTRODUCTION

Since the identification of mismatch-repair (MMR) gene mutations as the underlying cause of
Hereditary Nonpolyposis Colorectal Cancer (HNPCC) close to 500 mutations in more than 700 HNPCC families have been identified worldwide. 1 Mutation carriers are estimated to be at 70-80% life-time risk of colorectal cancer and 40-60% risk of endometrial cancer for female carriers and at increased risks also for ovarian cancer, urothelial cancer, gastric cancer, cancer of the small intestine, sebaceous adenomas/carcinomas, and gliomas. [2] [3] [4] Although the median age at development of colorectal cancer among probands in HNPCC families is 44 years, the age at diagnosis is highly variable with about 5% of the patients diagnosed before age 25 and at least one-third of the patients diagnosed after age 60. 2, 3 An increased risk of extraintestinal tumors has been described in MSH2 mutation carriers, whereas colorectal cancers predominate in individuals with mutations in MLH1 [5] [6] [7] . A lower incidence of colorectal cancer and later age at onset has been described in families with mutations in MSH6. 8 Despite the large number of HNPCC families identified, no strong genotype -phenotype correlations have been identified and the causes of the phenotypic variability in HNPCC are largely unknown.
A number of histopathological characteristics have been associated with colorectal cancers that develop as part of HNPCC and these characteristics are also overrepresented in the 15% of the sporadic colorectal cancers that develop because of defective MMR due to hypermethylation of the MLH1 promoter. [9] [10] [11] [12] These characteristics include a proximal tumor location, an expanding growth pattern, poor -sometimes medullary -differentiation, and mucinous histology. 9, [13] [14] [15] Additionally, HNPCC tumors tend to show abundant tumor-infiltrating lymphocytes (TIL) and peritumoral lymphocytes, and a Crohn-like lymphocytic reaction. [15] [16] [17] [18] Evaluation of these histopathological features, particularly mucinous, medullary, and poor differentiation and presence of TIL, has been shown to be valuable in predicting colorectal cancers with defective closely linked to tumors with a somatically acquired MMR defect 11 . We therefore histopathologically characterized all available tumors from two HNPCC-families with mutations in MLH1 and MSH2, respectively, in order to further clarify genotypic -phenotypic correlations.
Because of reports on frequent activation of the Wingless (Wnt) signaling pathway in HNPCCassociated tumors 19 we also chose to investigate the variability of β-catenin immunostaining in these tumors.
PATIENTS & METHODS
Patients
Two HNPCC families that had undergone genetic counseling and testing at the Oncogenetic clinic, Lund University Hospital were included in the study. Family C carried a c.1586delA 
Histopathology
Hematoxylin and erythrosin (H&E) stained slides were re-evaluated by a gastrointestinal pathologist (B.H.) and the majority of the cases were also reviewed by an additional pathologist (W.M.). Tumor stage of colorectal cancer was classified according to AJCC/UICC and tumor grade was determined according to the WHO classification 21 . Tumors with a mucinous or a signet ring-cell component identified in >50% of the tumor area were classified as mucinous or signet ring-cell type and were considered poorly differentiated. If a trabecular, solid or medullary growth pattern or a mucinous or signet ring-cell component encompassing 10-50% of the tumor area was identified, the tumors were classified as heterogenous. 11, 12 The tumor growth pattern was classified as expanding or infiltrative 13 . A Crohn-like infiltrate was defined as 3 or more nodular lymphoid aggregates deep to the advancing tumor margin within a single x 4 field.
Peritumoral lymphocytes were considered to be present when a cap of chronic inflammatory cells was seen in the deep invasive border of the tumor 11 . Presence of TIL was defined as 7 or more TIL / 10 HPF (x 40) on H&E stained slides. Infiltrating components and hot spot areas were primarily analyzed. TIL was not classified in early invasive (pT1sm1) tumors. In colorectal adenomas the grade of dysplasia was classified as high-grade or low-grade.
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Immunohistochemical staining The immunostainings for β-catenin (clone 14, 1:5000, Transduction Laboratories) were performed using the LSAB™ (labeled streptavidin-biotin) detection kit (Dako Cytomation). β-catenin staining is normally located to the cell membrane, but translocates to the cytoplasm and further into the nucleus in case of defective APC-directed degradation. β-catenin staining in the cytoplasm was classified as present or absent, and any nuclear β-catenin staining was classified as positive 19 . Whenever possible (in 26/29 colorectal cancers) the β-catenin staining was evaluated at the invasive border. All immunostainings were independently and concordantly evaluated by B.H. and M.N.
Statistical analysis
Statistical analysis was performed using the statistics package Stata 9.0 (StataCorp 2005, College
Station, TX, USA). Fisher's exact test was used to determine the correlation between morphology and tumor location / age.
RESULTS
Among the colorectal carcinomas, 10/29 (34%) were poorly differentiated, including one mucinous carcinoma, while 3 tumors were undifferentiated of the medullary type (Table 1) .
Furthermore, 16/29 (55%) colorectal carcinomas were classified as morphologically heterogenous with areas of mucinous or poor differentiation in less than 50% of the tumor tissue (Table 1) .
Peritumoral lymphocytic infiltration and TIL were observed in 22/28 (79%) and 16/26 (62%) of the tumors, whereas a Crohn-like lymphocytic reaction was found in 11/25 (44%) tumors. An expanding growth pattern was identified in 17/25 (68%) colorectal carcinomas (Table 1) . Several features such as poor tumor differentiation, an expanding growth pattern, and TIL were significantly more often identified in cancers within the proximal colon compared to those in the distal colon or in the rectum (Table 2) . Among patients >50 years at diagnosis an expanding growth pattern occurred at increased frequency (13/15 compared to 4/10 in younger patients, p=0.03), whereas the other morphological variables did not correlate with age (data not shown).
Of the 12 colorectal adenomas investigated, 10 were tubular, 2 were tubulovillous, and 4/12
showed high-grade dysplasia. The adenomas developed at mean age 65 (range 44-78) years and were equally distributed between the proximal and the distal colon.
Although disease-causing germline mutations in MSH2 and MLH1 had been identified in all 24 individuals, MMR protein immunostaining was performed in order to confirm a MMR defective phenotype, which was indeed present in all tumors except for one colon cancer and 2 colon adenomas that showed retained expression of all 4 MMR proteins investigated and microsatellite instability (MSI) analysis confirmed a microsatellite stable phenotype in these tumors (Table 1) .
Cytoplasmic accumulation of β-catenin was identified in 23/29 (79%) colorectal cancers and in all 12 adenomas and nuclear β-catenin accumulation was observed in 4 colorectal cancers and 3 adenomas (Table 1) .
DISCUSSION
Genetic as well as phenotypic heterogeneity characterizes HNPCC; mutations in different MMR genes cause morphologically indistinguishable colorectal cancers, but mutations in the same gene may also lead to highly variable phenotypes. In our series, extensive inter-as well as intra-tumor heterogeneity for histopathological and immunohistochemical features was identified. Ages at onset of colorectal cancer varied from 39 to 78 years in the MSH2 family and from 23 to 61 years in the MLH1 family with co-existence of early-onset and late-onset cancers in both families. A variable age at cancer development has also been observed in families carrying the two Finnish MLH1 founder mutations, which emphasizes that factors other than the underlying germline alteration influence the HNPCC phenotype. 6 Double primary tumors develop in about one-third of HNPCC patients; synchronous colorectal cancers develop in 5-10% of the patients and metachronous colorectal cancers in 20-25% with mean 10 years between the different tumors. 23 Among the 6 individuals who developed at least 2 colorectal cancers, differences in tumor morphology and immunostaining were observed in all cases ( Table 1 , Fig. 1 ). Three tumors -one colon carcinoma and two adenomas -showed a MSS phenotype with retained immunostaining, which may, particularly for the adenomas, reflect that occasional HNPCC tumors escape identification with currently used methods, which identify defective MMR with a sensitivity of about 95% for carcinomas and 60-70% for adenomas 24 .
Poor/undifferentiated tumor differentiation has been described in 30-40% of the HNPCC-tumors and was in our series identified in 45% of the tumors. 9, 11, 14, 25 An expanding tumor margin has also been associated with HNPCC, although not consistently identified as over-represented, and was in our series observed in 68% of the colorectal cancers. 9, 14 Morphologic heterogeneity with mucinous, signet ring-cell, or medullary components has been described as a common characteristic within HNPCC tumors and was in our series present in 55% of the tumors. 11, 15, 16 Abundant lymphocytes, which may appear as Crohn-like reactions, as peritumoral lymphoctes or as TIL are among the features most frequently observed in HNPCC-associated colorectal cancers. 11, 12 In our series, TIL were identified in 59% of the colorectal cancers, whereas a Crohn-like reaction was identified in 44% of the tumors. Assessment of TIL has been described to identify MMR-defective colorectal cancers with a sensitivity of 75-90%. 15, 18, 25, 26 The biological significance of these lymphocytes is still unknown, but may be related to an inflammatory response from cytotoxic T-cells in MMR-defective tumors. Differences exist between sporadic and HNPCC-associated MMR-defective tumors. Serrated polyps, somatic BRAF gene mutations, and MLH1 methylation characterize the sporadic tumors, whereas conventional colorectal adenomas seem to be the precursor lesions in HNPCC with mutations in APC, β-catenin, and KRAS occuring at a higher frequency. 27 The morphological parameters investigated herein have been associated with MMR-defective tumors in general, but may be particularly associated with somatic MMR-defects.
Rectal cancer has been reported to be the index cancer in one out of four HNPCC patients, which stands in contrast to the sporadic MMR-defective tumors, 90% of which develop in the proximal colon. 16, 28 In our series, 19 colorectal cancers developed in the proximal colon and 10 in the distal colon or the rectum. Among the HNPCC-associated features, poor tumor differentiation, an expanding growth pattern, and TIL were significantly more common in proximal than in distal colorectal cancers (Table 2) . Hence, identification of HNPCC cases among distal colon cancers based on tumor morphology may be challenging since these tumors often lack distinct HNPCCassociated features, but at the same time identification of a MMR defective phenotype is more likely to reflect HNPCC in the distal tumors because of a low frequency of somatic MMRdefects.
Overactivation of the Wnt signaling pathway favors cell growth. β-catenin is normally directed to ubiquitin-mediated degradation through interaction with the adenomatous polyposis coli (APC)
protein.
Since mutations in APC and CTNNB1 occur at high frequency in colorectal cancer, defective β-catenin expression with cytoplasmic accumulation and nuclear translocation is common and mutations in the regulatory domain of β-catenin have been described at an increased frequency in HNPCC-associated tumors. 30 Cytoplasmic accumulation of β-catenin was identified in 79% of the colorectal cancers and in all adenomas ( Table 1 ). The staining varied in between different tumors from the same individual as well as between different family members with identical mutations and seemed equally common in individuals with MLH1 and MSH2 mutations.
We also morphologically and immunohistochemically characterized 9 gynecological cancers from 8 individuals, 7 of whom carried the MSH2 mutation and 4 of whom also developed colorectal cancers (data not shown). The 7 endometrial cancers developed at a mean age of 49 (range 40-60) years, which is consistent with the reported mean age of 50 years. Poor differentiation, Crohn-like lymphoid reactions, and TIL are overrepresented in MMR-defective endometrial cancers but similarly to colorectal cancer these patterns seem to be more common in the somatically inactivated tumors, whereas the HNPCC-associated tumors show a more variable morphology. 31 Only 1/7 endometrial cancers in our series was poorly differentiated, lymphocytic infiltration was identified in 4, and 6 of the 7 tumors showed cytoplasmic accumulation of β-catenin staining (data not shown). Ovarian cancers associated with HNPCC are characterized by early tumor development, mean age 41-43 years, which is consistent with the two cases that developed at ages 40 and 45 years. 32 Both patients had clear cell cancers of the ovaries and synchronous early stage endometrial cancers of low grade differentiation and because of the distinct morphologies the tumors were in both cases considered to be separate.
In summary, the histopathological characteristics and the immunohistochemical staining patterns 
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